Project
EUnetCCC
The European Comprehensive Cancer Centre Network
1 October 2024 - 30 September 2028

The primary objective of the EU Comprehensive Cancer Centers (CCC) network is to create a cohesive and integrated consortium of CCCs across Europe to ensure that all patients, regardless of their location, have access to high-quality care. This network will also serve as a platform for collaboration, allowing centres to share best practices, resources, and knowledge. Such collaboration is essential in promoting research, integrating the latest findings into clinical care, and ensuring that patients benefit from the most effective treatments available.
Project description
Comprehensive Cancer Centres (CCCs) are at the forefront of cancer research, treatment, and education. Their multidisciplinary approach ensures that patients benefit from the latest scientific advancements, from early detection to innovative treatments and post-treatment care. The establishment of the European Comprehensive Cancer Centre (EUCCC) network represents a harmonised and integrated approach to cancer care across the continent. This initiative is rooted in the principles of excellence and collaboration.
As a follow-up project to CRANE: Joint Action on Network of Comprehensive Cancer Centres, the primary objective of the EU CCC network is to create a cohesive and integrated consortium of CCCs across Europe to ensure that 90% of eligible patients, regardless of their location, have access to high-quality care. This network also serves as a platform for collaboration, allowing Centres to share and develop together best practices, resources, and knowledge. Such collaboration is essential in promoting research, integrating the latest findings into clinical care, and ensuring that patients benefit from the most effective treatments available. The network will facilitate the adoption of quality diagnostic and treatment methods, including training, research and clinical trials across the EU. It should contribute to:
- reducing inequalities of diagnosis, treatment and care, and access to clinical trials;
- strengthening the quality of outcomes research;
- integrating clinical care and research and evaluating the quality of cancer care throughout.
Funding programme & Type of action
Funding programme : EU4 Health Programme (EU4H)
Type of action : Joint Action
Grant agreement number : 101183407
Duration
years : 4
Consortium
- Number of countries involved: 35
- Number of partners involved: 166
Belgian partners
- Sciensano
- Universitair Ziekenhuis Antwerpen
- Katholieke Universiteit Leuven
- Cliniques Universitaires Saint-Luc ASBL
- Universiteit Gent
- Association Hospitalière de Bruxelles — centre Hospitalier Universitaire Jules Bordet
- VIB VZW
- Belgische Vereniging voor Medische Oncologie / Société Belge d’Oncologie Médicale
- Vrije Universiteit Brussel